Pip/Taz and Y-Site Compatibility

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

Praziquantel86

Full Member
Moderator Emeritus
10+ Year Member
Advertisement - Members don't see this ad
We're in the process of switching over our ICUs to extended-infusion dosing of pip/taz; but I'm having some issues finding data on compatibility with some of the more common drips you'd see in an ICU (norepinephrine, insulin, etc.). Most of the data that I've been able to find predates the reformulation with EDTA, so I'm a bit leery of trusting it. I called Wyeth, but they weren't much help either.

Does anyone here have suggestions? Published data would be great, but any sort of practical experience that you might have had would also be appreciated.
 
Advertisement - Members don't see this ad
That was one of the places I looked, most (all?) their data was from before the reformulation.

Ok..then my data is old... hound Wyeth. They need to provide the info. Don't take "NO" for an answer. Keep calling... and when they give you and answer you don't want...say..

"That is not acceptable." And stay silent. Let them come back to you with a response and solution.
 
Ok..then my data is old... hound Wyeth. They need to provide the info. Don't take "NO" for an answer. Keep calling... and when they give you and answer you don't want...say..

"That is not acceptable." And stay silent. Let them come back to you with a response and solution.

Fair enough...hopefully playing hardball works.

I was also debating calling up Apotex and asking what they have. They're currently marketing the generic up in Canada, which (hopefully) will follow here shortly.
 
Fair enough...hopefully playing hardball works.

I was also debating calling up Apotex and asking what they have. They're currently marketing the generic up in Canada, which (hopefully) will follow here shortly.


But generic Apotex vial is pre-reformulation dude..